**Core Concept**
Hemophilia is a genetic disorder characterized by a deficiency in one of the clotting factors necessary for blood coagulation. This leads to prolonged bleeding, especially after injuries or surgeries. The key underlying principle being tested is the coagulation cascade and the role of clotting factors in hemostasis.

**Why the Correct Answer is Right**
The correct answer is related to the pathophysiology of hemophilia, where the deficiency of clotting factors leads to impaired blood coagulation. Specifically, the lack of factor VIII (in Hemophilia A) or factor IX (in Hemophilia B) results in a failure to form a stable fibrin clot, leading to prolonged bleeding. This is due to the inability of the coagulation cascade to proceed normally, resulting in a failure to activate the final common pathway and form a stable clot.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because it does not accurately reflect the pathophysiology of hemophilia. While an increase in certain clotting factors may occur as a compensatory mechanism, it is not the primary manifestation of the disease.
* **Option B:** This option is incorrect because it is unrelated to the coagulation cascade and the role of clotting factors in hemophilia.
* **Option C:** This option is incorrect because it is not a direct consequence of the deficiency of clotting factors in hemophilia.

**Clinical Pearl / High-Yield Fact**
In hemophilia, the deficiency of clotting factors can lead to severe and prolonged bleeding, especially after minor trauma. It is essential to recognize the clinical manifestations of hemophilia, including joint deformities, muscle weakness, and anemia, and to initiate prompt treatment with clotting factor replacement therapy.

**Correct Answer:** D.